The prognostic utility of the “Tumor Burden Score” based on preoperative radiographic features of colorectal liver metastases

Recently, a tumor‐burden “metro ticket” score (TBS) based on final pathology was proposed to predict outcome following resection of colorectal liver metastasis (CRLM). We sought to validate the TBS prognostic tool using preoperative radiologic cross‐sectional imaging.

[1]  M. Unno,et al.  Colorectal Liver Metastases: A Critical Review of State of the Art , 2016, Liver Cancer.

[2]  A. Dennison,et al.  Clinical risk scores in the current era of neoadjuvant chemotherapy for colorectal liver metastases , 2016, ANZ journal of surgery.

[3]  M. Choti,et al.  Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases , 2015, Annals of Surgical Oncology.

[4]  M. Pérez,et al.  Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents , 2015, Targeted Oncology.

[5]  B. Sangro,et al.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Steven A. Curley,et al.  RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases , 2013, Annals of surgery.

[7]  Jianming Xu,et al.  Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Myeong-Jin Kim,et al.  Response evaluation in patients with colorectal liver metastases: RECIST version 1.1 versus modified CT criteria. , 2012, AJR. American journal of roentgenology.

[9]  E. Van Cutsem,et al.  The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. , 2012, The oncologist.

[10]  M. A. van den Bosch,et al.  Preoperative Imaging of Colorectal Liver Metastases After Neoadjuvant Chemotherapy: A Meta-Analysis , 2012, Annals of Surgical Oncology.

[11]  A. Eggermont,et al.  Is the Clinical Risk Score for Patients with Colorectal Liver Metastases Still Useable in the Era of Effective Neoadjuvant Chemotherapy? , 2011, Annals of Surgical Oncology.

[12]  D. Gorden,et al.  Utility or futility of prognostic scoring systems for colorectal liver metastases in an era of advanced multimodal therapy. , 2010, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[13]  M. Ducreux,et al.  Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  H. Lang,et al.  Clinical scoring systems for predicting outcome after surgery for colorectal liver metastases: towards a better multidisciplinary approach , 2009, Liver international : official journal of the International Association for the Study of the Liver.

[15]  A. Hill,et al.  Hepatic resection for colorectal metastases. Value for risk scoring systems? , 2008, Annals of surgery.

[16]  V. Mazzaferro Results of liver transplantation: With or without milan criteria? , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[17]  J. Donohue,et al.  Hepatic Resection for Colorectal Metastases: Value for Risk Scoring Systems? , 2007, Annals of surgery.

[18]  Douglas G Altman,et al.  Dichotomizing continuous predictors in multiple regression: a bad idea , 2006, Statistics in medicine.

[19]  O. Garden,et al.  Prognostic scoring in colorectal cancer liver metastases: development and validation. , 2005, Archives of surgery.

[20]  D. Nitti,et al.  Patterns of Recurrence after Resection of Colorectal Liver Metastases: Prediction by Models of Outcome Analysis , 2001, World Journal of Surgery.

[21]  T. Starzl,et al.  Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. , 1999, Journal of the American College of Surgeons.

[22]  L H Blumgart,et al.  Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. , 1999, Annals of surgery.

[23]  B. Nordlinger,et al.  Surgical resection of colorectal carcinoma metastases to the liver: A prognostic scoring system to improve case selection, based on 1568 patients , 1996, Cancer.

[24]  D. Ilstrup,et al.  Resection of hepatic metastases from colorectal cancer. , 1984, Archives of surgery.

[25]  J. Hanley,et al.  A method of comparing the areas under receiver operating characteristic curves derived from the same cases. , 1983, Radiology.

[26]  J. Hanley,et al.  The meaning and use of the area under a receiver operating characteristic (ROC) curve. , 1982, Radiology.

[27]  I. Endo,et al.  The Tumor Burden Score: A New “Metro-ticket” Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors , 2018, Annals of surgery.

[28]  M. Gönen,et al.  Colorectal Cancer Liver Metastases and Concurrent Extrahepatic Disease Treated With Resection , 2016, Annals of surgery.

[29]  J. Weitz,et al.  Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. , 2010, The Lancet. Oncology.

[30]  L. Schwartz,et al.  New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.

[31]  H. Ueno,et al.  Indicators for treatment strategies of colorectal liver metastases. , 2000, Annals of Surgery.

[32]  J. Kovalevsky Results of the , 1975 .

[33]  Surgery for colorectal liver metastases: The evolution of determining prognosis , 2022 .